Jane Street’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-52,609
Closed -$63K 6645
2022
Q3
$63K Sell
52,609
-47,081
-47% -$56.4K ﹤0.01% 5042
2022
Q2
$180K Sell
99,690
-294,220
-75% -$531K ﹤0.01% 4507
2022
Q1
$796K Buy
393,910
+197,933
+101% +$400K ﹤0.01% 3224
2021
Q4
$531K Sell
195,977
-30,851
-14% -$83.6K ﹤0.01% 3396
2021
Q3
$1.01M Sell
226,828
-131,343
-37% -$586K ﹤0.01% 2626
2021
Q2
$2.08M Buy
358,171
+253,540
+242% +$1.47M ﹤0.01% 1739
2021
Q1
$735K Sell
104,631
-72,047
-41% -$506K ﹤0.01% 2888
2020
Q4
$849K Buy
176,678
+87,722
+99% +$422K ﹤0.01% 2274
2020
Q3
$519K Buy
+88,956
New +$519K ﹤0.01% 2405
2020
Q2
Sell
-43,887
Closed -$279K 4658
2020
Q1
$279K Sell
43,887
-212,235
-83% -$1.35M ﹤0.01% 2632
2019
Q4
$2.67M Buy
256,122
+243,968
+2,007% +$2.54M ﹤0.01% 768
2019
Q3
$47K Sell
12,154
-27,932
-70% -$108K ﹤0.01% 3266
2019
Q2
$596K Sell
40,086
-3,953
-9% -$58.8K ﹤0.01% 2112
2019
Q1
$1.09M Sell
44,039
-24,170
-35% -$600K ﹤0.01% 1593
2018
Q4
$1.23M Buy
68,209
+44,814
+192% +$805K ﹤0.01% 1275
2018
Q3
$687K Buy
23,395
+5,317
+29% +$156K ﹤0.01% 2065
2018
Q2
$822K Buy
18,078
+7,893
+77% +$359K ﹤0.01% 1833
2018
Q1
$538K Sell
10,185
-10,916
-52% -$577K ﹤0.01% 2077
2017
Q4
$1.44M Sell
21,101
-51,787
-71% -$3.52M ﹤0.01% 1105
2017
Q3
$6.01M Buy
72,888
+10,634
+17% +$876K 0.02% 358
2017
Q2
$5.83M Buy
62,254
+44,560
+252% +$4.17M 0.02% 325
2017
Q1
$1.13M Buy
+17,694
New +$1.13M 0.01% 1139
2016
Q4
Sell
-45,606
Closed -$1.64M 3198
2016
Q3
$1.64M Buy
45,606
+25,844
+131% +$932K 0.01% 852
2016
Q2
$271K Buy
+19,762
New +$271K ﹤0.01% 2159
2016
Q1
Sell
-15,182
Closed -$531K 3159
2015
Q4
$531K Sell
15,182
-11,238
-43% -$393K ﹤0.01% 1529
2015
Q3
$2.43M Buy
+26,420
New +$2.43M 0.02% 480
2015
Q2
Sell
-5,825
Closed -$432K 2949
2015
Q1
$432K Buy
+5,825
New +$432K ﹤0.01% 1535
2013
Q4
Sell
-20,275
Closed -$1.23M 2742
2013
Q3
$1.23M Buy
20,275
+10,984
+118% +$668K 0.01% 758
2013
Q2
$622K Buy
+9,291
New +$622K 0.01% 1041